Edward J. Dulac III, Chief Financial Officer at FATE THERAPEUTICS INC (FATE), sold 38,920 shares at $62.53 ($2.4M) on 2021-09-28, disclosed to the SEC on 2021-09-30.
Open-market sale of $2.4M FATE by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $62.53 | 19,460 | $1.2M | 50.0% |
| 2 | $62.53 | 19,460 | $1.2M | 50.0% |
| Total | $62.53 avg | 38,920 | $2.4M | 100% |
| Filing → |
| NTLA | SELL | 2026-01-07 | $59K | — | Filing → |
| NTLA | SELL | 2025-07-25 | $209K | — | Filing → |
| FATE | SELL | 2024-03-05 | $19K | — | Filing → |